Diabetes is a significant health-care challenge. According to the Centers for Disease Control, 30.4 million Americans have diabetes, and one-in-four of them don’t know they have it. There are 84 million people with pre-diabetes, according to the CDC. What is your practice doing to serve these people? Not only is taking care of these patients by addressing their diabetes the right thing to do; it’s a great practice-builder.
Researchers have drafted a review on how FAF can facilitate the diagnosis and monitoring of posterior uveitis and panuveitis.
Markers in the blood that predict whether glaucoma patients are at higher risk of continued loss of vision following conventional treatment have been identified by researchers.
Cycloplegic refraction makes it possible to accurately measure a child’s refractive error and provide appropriate correction.
The custom-built robot was used to treat wet neovascular age-related macular degeneration (AMD).
Researchers have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD).
Scientists report that a gene could be key to understanding why many people don't benefit from the most used therapy for neovascular age-related macular degeneration (AMD), a leading cause of blindness.
A group of researchers have created an exceptionally small implant, with electrodes the size of a single neuron that can also remain intact in the body over time.
An intentional focus on diabetes enhances patient outcomes and has a substantial impact on the overall success and sustainability of optometry practices.
A landmark resolution marks a significant step forward in recognizing the profound threat that climate change poses to global public health, including its impacts on eye care.